Olga Maiz
San Sebastian, PV, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients.
Journal: Seminars in arthritis and rheumatism
Published: September 30, 2025
SUBCUTANEOUS VERSUS INTRAVENOUS TOCILIZUMAB IN AORTITIS ASSOCIATED WITH GIANT CELL ARTERITIS: MULTICENTER STUDY OF 196 PATIENTS.
Journal: Arthritis care & research
Published: August 26, 2025
Subcutaneous Versus Intravenous Tocilizumab in Aortitis Associated With Giant Cell Arteritis: Multicenter Study of 196 Patients.
Journal: Arthritis care & research
Published: August 26, 2025
Tocilizumab monotherapy versus combined in aortitis associated with giant cell arteritis: Factors associated with imaging remission in a multicenter open-label study of 196 patients.
Journal: Seminars in arthritis and rheumatism
Published: June 30, 2025
Corrigendum to "Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice" [Seminars in Arthritis and Rheumatism 71 (2025) 152640].
Journal: Seminars in arthritis and rheumatism
Published: February 18, 2025
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice.
Journal: Seminars in arthritis and rheumatism
Published: August 30, 2024
Tocilizumab in cranial and extracranial giant cell arteritis: a national multicentre study of 471 cases.
Journal: Rheumatology (Oxford, England)
Published: August 29, 2024
Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature.
Journal: Arthritis research & therapy
Published: February 06, 2024
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis.
Journal: European journal of internal medicine
Published: December 06, 2023
Long-term follow-up of certolizumab pegol in uveitis due to immune-mediated inflammatory diseases: multicentre study of 80 patients.
Journal: RMD open
Published: August 25, 2022
Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients.
Journal: Clinical and experimental rheumatology
Published: June 12, 2022
Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients.
Journal: Therapeutic advances in musculoskeletal disease
Published: February 26, 2022
Last Updated: 09/26/2026